Dingwei Xue
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 12
- Photoacoustic and Ultrasonic Imaging 2
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Materials Chemistry top 10%
- Luminescence and Fluorescent Materials 6
- Biophysics top 10%
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 4
- Renal and related cancers 2
-
- Renal cell carcinoma treatment 2
Dingwei Xue
27 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Biomedical Engineering 850
- Cancer Research 248
- Materials Chemistry 617
- Biophysics 43
- Molecular Biology 499
Countries citing papers authored by Dingwei Xue
This map shows the geographic impact of Dingwei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingwei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingwei Xue more than expected).
Fields of papers citing papers by Dingwei Xue
This network shows the impact of papers produced by Dingwei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingwei Xue. The network helps show where Dingwei Xue may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dingwei Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 28 | |
| 5 | 2022 | 78 | |
| 6 | 2022 | 50 | |
| 7 | 2022 | 20 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 84 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 50 | |
| 14 | 2020 | 12 | |
| 15 | 2019 | 7 | |
| 16 | 2019 | 67 | |
| 17 | 2019 | 124 | |
| 18 | 2019 | 62 | |
| 19 | 2018 | 214 | |
| 20 | 2017 | 14 |
About Dingwei Xue
Dingwei Xue is a scholar working on Cancer Research, Biomedical Engineering, Materials Chemistry, Molecular Biology and Speech and Hearing, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Luminescence and Fluorescent Materials (6 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (4 papers), Renal cell carcinoma treatment (2 papers), Renal and related cancers (2 papers) and Photoacoustic and Ultrasonic Imaging (2 papers). The work is most often cited by research in Biomedical Engineering (850 citations), Cancer Research (248 citations), Materials Chemistry (617 citations), Biophysics (43 citations) and Molecular Biology (499 citations). Dingwei Xue has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jun Qian, Gonghui Li, Nuernisha Alifu, Xiaoming Yu, Abudureheman Zebibula, Liqun Xia, Chaowei Sun, Xiaoxiao Fan, Jie Liu and Wei Huang. Their work appears in journals such as Advanced Functional Materials, ACS Nano, ACS Applied Materials & Interfaces, Molecular Cancer and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.